Harpoon Therapeutics, Inc. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018
Revenue
Collaboration and license revenue
Collaboration and License
Total revenue

Operating expenses
Research and development
General and administrative
Litigation settlement
Total operating expenses
Loss from operations
Interest income
Other expense
Net loss and comprehensive loss
Net loss
Other comprehensive loss:
Net unrealized gain (loss) on marketable securities
Comprehensive loss
Net loss per share, basic
Net loss per share, diluted
Weighted-average shares used in computing net loss per share, basic
Weighted-average shares used in computing net loss per share, diluted

Comments